Lupin gets FDA nod for generic Prozac
Lupin has received the Food and Drug Administration’s blessing for its generic Prozac (fluoxetine tablets), in a 60-mg dosage strength.
It is indicated in the treatment of major depressive disorder, obsessive compulsive disorder, bulimia nervosa, and panic disorder, with or without agoraphobia.
Fluoxetine tablets, 60-mg, had a market value of approximately $42.5 million, according to December 2018 IQVIA data.
It is indicated in the treatment of major depressive disorder, obsessive compulsive disorder, bulimia nervosa, and panic disorder, with or without agoraphobia.
Fluoxetine tablets, 60-mg, had a market value of approximately $42.5 million, according to December 2018 IQVIA data.